PharmEnable Therapeutics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Later Stage VC
- Investors
-
23
PharmEnable Therapeutics General Information
Description
Developer of a molecule drug designed to replicate the specificity of biologics in the form of small molecules. The company uses a unique and diverse virtual compound library in conjunction with computational screening programs to identify novel active chemical starting points against the most challenging biological targets, enabling the medical community to develop medicines such as a novel antibacterial agent or cancer treatment.
Contact Information
Website
www.pharmenabletx.comCorporate Office
- Compass House, Vision Park
- Histon
- Cambridge CB24 9AD
- England, United Kingdom
Corporate Office
- Compass House, Vision Park
- Histon
- Cambridge CB24 9AD
- England, United Kingdom
PharmEnable Therapeutics Timeline
PharmEnable Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | Completed | Generating Revenue | ||||
| 6. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 20-Jul-2023 | Completed | Generating Revenue | |||
| 4. Seed Round | 28-Apr-2020 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 10-Oct-2017 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2017 | Completed | Startup | |||
| 1. University Spin-Out | 17-Oct-2016 | Completed | Startup |
PharmEnable Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 | ||||||||
| Series A | ||||||||
| Ordinary | 927,083 | $0.000013 | $2.56 | $2.56 | 1x | $2.56 | 28.55% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
PharmEnable Therapeutics Comparisons
Industry
Financing
Details
PharmEnable Therapeutics Competitors (2)
One of PharmEnable Therapeutics’s 2 competitors is Biorelate, a Venture Capital-Backed company based in Manchester, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Biorelate | Venture Capital-Backed | Manchester, United Kingdom | ||||
| BioSymetrics | Formerly VC-backed | New York, NY |
PharmEnable Therapeutics Signals
PharmEnable Therapeutics Investors (23)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BioIndustry Association | Accelerator/Incubator | |||
| Arrowfield Capital | Angel Group | Minority | ||
| EMV Capital | Venture Capital | Minority | ||
| Heyford Trust | Corporation | Minority | ||
| Meltwind Advisory | Venture Capital | Minority |
PharmEnable Therapeutics FAQs
-
When was PharmEnable Therapeutics founded?
PharmEnable Therapeutics was founded in 2016.
-
Where is PharmEnable Therapeutics headquartered?
PharmEnable Therapeutics is headquartered in Cambridge, United Kingdom.
-
What is the size of PharmEnable Therapeutics?
PharmEnable Therapeutics has 13 total employees.
-
What industry is PharmEnable Therapeutics in?
PharmEnable Therapeutics’s primary industry is Drug Discovery.
-
Is PharmEnable Therapeutics a private or public company?
PharmEnable Therapeutics is a Private company.
-
What is PharmEnable Therapeutics’s current revenue?
The current revenue for PharmEnable Therapeutics is .
-
How much funding has PharmEnable Therapeutics raised over time?
PharmEnable Therapeutics has raised $10.2M.
-
Who are PharmEnable Therapeutics’s investors?
BioIndustry Association, Arrowfield Capital, EMV Capital, Heyford Trust, and Meltwind Advisory are 5 of 23 investors who have invested in PharmEnable Therapeutics.
-
Who are PharmEnable Therapeutics’s competitors?
Biorelate and BioSymetrics are competitors of PharmEnable Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process